{
  "pmcid": "5919242",
  "sha256": "ef74746cdba077dc0909b7526d8a2df46d21daaf88ff458f14871635ef3bf0b7",
  "timestamp_utc": "2025-11-09T23:59:49.761992+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 9.13222146274778,
    "reading_ease": 51.12438140806563,
    "word_count": 266
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial Comparing Patellofemoral Arthroplasty and Total Knee Arthroplasty for Severe Patellofemoral Osteoarthritis"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised to receive either PFA or TKA."
      },
      "Participants": {
        "score": 2,
        "evidence": "100 patients with debilitating symptoms and isolated patellofemoral disease were recruited from 2007 to 2014."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive either PFA or TKA."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the outcomes of patellofemoral arthroplasty (PFA) versus total knee arthroplasty (TKA) in patients with severe patellofemoral osteoarthritis."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the area under the curve (AUC) for SF-36 bodily pain over 2 years."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Randomisation was blinded for the first year and quasi-blinded to assessors."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Randomisation was blinded for the first year and quasi-blinded to assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "100 patients with debilitating symptoms and isolated patellofemoral disease were recruited from 2007 to 2014."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "The analysis was conducted using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The AUC for SF-36 bodily pain was significantly better for PFA (9.2 months, SD 4.3) compared to TKA (6.5 months, SD 4.5; p = 0.008)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant difference in complications was observed."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The trial was registered, and funding sources were disclosed."
      },
      "Funding": {
        "score": 1,
        "evidence": "The trial was registered, and funding sources were disclosed."
      }
    },
    "total_score": 22,
    "max_score": 25
  }
}